Clinton's China trip spurs US investment
This article was originally published in Clinica
The visit of US President Clinton to China was accompanied by a flurry of announcements of investment, including a number in the medical technology field. Chindex, an independent US distributor of various manufacturer's equipment in China, Hong Kong and Macau, has announced a letter of intent for $15 million, while Hewlett-Packard has a memorandum of understanding for a further $10 million.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.